银屑病表皮中CDK2活性上调而CDK4活性受抑制
该研究纳入24例银屑病患者,比较斑块与非皮损皮肤的CDK2、CDK4及其周期蛋白和抑制蛋白表达与活性。结果显示银屑病表皮CDK2-cyclin E表达和活性显著增加,而CDK4-cyclin D1活性完全受抑制;p27表达降低,p16和p21表达诱导。这些改变不涉及CDK转录变化,而由翻译后调控介导。
要点
- 银屑病表皮CDK2-cyclin E表达和活性显著增加。
- CDK4-cyclin D1活性完全受抑制,尽管其表达增加。
- p27表达降低、p16和p21表达诱导参与翻译后调控。
核心结论
- 银屑病表皮CDK2活性增加而CDK4活性完全受抑制,这些改变由p27降低和p16过表达等翻译后调控介导。
研究设计与样本
- 研究纳入24例银屑病患者,从慢性斑块和非皮损皮肤取活检。
- 采用免疫印迹、免疫组化、免疫荧光、实时PCR和荧光肽生物传感器评估CDK2、CDK4、cyclin D1、cyclin E及CKI表达和激酶活性。
主要发现
- 银屑病表皮CDK2-cyclin E表达和活性较邻近非皮损皮肤显著增加。
- 银屑病表皮CDK4-cyclin D1活性受抑制,尽管其表达增加且转录轻度抑制。
- 银屑病表皮p27表达降低,而p16和p21表达诱导。
关键数值与推荐
- CDK2-cyclin E表达和活性在银屑病表皮显著增加(P值未报告)。
- CDK4-cyclin D1活性在银屑病表皮完全受抑制(P值未报告)。
- p27表达降低,p16和p21表达诱导(P值未报告)。
临床怎么用
- 药理学调控CDK2和CDK4可能成为银屑病有前景的治疗策略。
局限性
- 样本量24例,结论需更大队列验证。
- 未报告具体P值和效应量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The cyclin-dependent kinases (CDKs) CDK2 and CDK4 are involved in regulation of cell-cycle progression, and psoriasis is characterized by hyperproliferation of basal epidermal cells. CDK inhibitory proteins (CKIs) such as p16INK 4A (p16) bind CDK4/6 kinases and prevent their interaction with D-type cyclins. CKIs such as p21Cip1 (p21) and p27Kip1 (p27) associate with CDK-cyclin complexes and prevent their activation. OBJECTIVES: To gain insight into the molecular implication of CDK2 and CDK4 kinases in psoriasis, we sought to characterize expression of these kinases and associated cyclins, as well as of CKIs, and addressed the status of CDK2 and CDK4 activity in human psoriatic epidermis. METHODS: A cohort of 24 patients with psoriasis participated in the study. Biopsies were removed from a chronic plaque and from nonlesional skin. CDK2, CDK4, cyclin D1, cyclin E and CKI protein expression was assessed by immunoblotting, immunohistochemistry and immunofluorescence. CDK4 and CDK2 mRNA expression was determined by real-time polymerase chain reaction. Specific kinase activities of CDK2 and CDK4 were evaluated using fluorescent peptide biosensors. RESULTS: CDK2-cyclin E expression and activity were significantly increased in psoriatic epidermis compared with uninvolved adjacent skin. In contrast, CDK4-cyclin D1 activity was inhibited, although its expression was increased in psoriatic epidermis and its transcription slightly inhibited. p27 expression was reduced, while p16 and p21 expression was induced in psoriatic epidermis. CONCLUSIONS: Epidermal CDK2 activity is increased in psoriatic epidermis while CDK4 activity is completely inhibited. These alterations are not associated with changes in CDK transcription and instead involve post-translational control mediated by decreased expression of p27 and p16 overexpression, respectively. What's already known about this topic? Cyclin-dependent kinases (CDKs) are involved in cell-cycle progression. The levels of cyclin partners and CDK inhibitors regulate their activity. Psoriasis is a chronic T-cell-driven inflammatory skin disease characterized by hyperproliferation of basal epidermal cells. What does this study add? Thanks to fluorescent peptide biosensors, this study demonstrates that epidermal CDK2 activity is increased in psoriatic epidermis while CDK4 activity is completely inhibited. These alterations involve post-translational control mediated by decreased expression of p27, and p16 overexpression, respectively. What is the translational message? CDK2 and CDK4 are involved in regulation of cell-cycle progression, and psoriasis is characterized by hyperproliferation of basal epidermal cells. Epidermal CDK2 activity is increased in psoriatic epidermis while CDK4 activity is completely inhibited. These alterations are not associated with changes in CDK transcription and instead involve post-translational control mediated by decreased expression of p27 and p16 overexpression, respectively. Pharmacological modulation of CDK2 and CDK4 may constitute a promising therapeutic strategy.
引用
- Henri P, Prevel C, Pellerano M, et al. Psoriatic epidermis is associated with upregulation of CDK2 and inhibition of CDK4 activity. Br J Dermatol. 2019. PMID: 31145809. doi:10.1111/bjd.18178
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。